Patent · US Active

Once daily formulations of tetracyclines

US8709478B2 · kind B2 · utility

5Cited by

76References

37Claims

0Family size

Assignee

Supernus Pharmaceuticals, Inc. · US

Inventors

Rong-Kun Chang · Rockville, US
Arash Raoufinia · McLean, US
Niraj Shah · Issaquah, US

Key dates

Filing date	Jun 18, 2013
Grant date	Apr 29, 2014
Priority date	—
Expiry date	Jun 18, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.